The Rutgers Health-RWJ Scleroderma Program An Overview

Scleroderma is a chronic autoimmune disorder that affects the connective tissue in the body, leading to hardening of the skin and tissue. The Rutgers Health-RWJ Scleroderma Program is a comprehensive program that provides comprehensive care for patients living with scleroderma. This program is focused on improving the quality of life of patients living with this condition, providing them with the best care available and the latest treatments. This article provides an overview of the Rutgers Health-RWJ Scleroderma Program and its various services.

Table of Contents

Overview of the Rutgers Health-RWJ Scleroderma Program

The Rutgers Health-RWJ Scleroderma Program is a comprehensive program dedicated to providing the best care available to those living with scleroderma. The program is designed to improve the quality of life of people living with the condition and to provide them with the latest treatments. The program is led by a multidisciplinary team of physicians, nurses, and other healthcare professionals who specialize in the treatment and care of patients with scleroderma. The team is comprised of experts in the fields of rheumatology, dermatology, pulmonology, cardiology, and more. The team works together to develop individualized treatment plans that are tailored to the needs of each patient. The program also provides supportive services such as counseling, educational programs, and patient support groups.

Treatment and Care Services

The Rutgers Health-RWJ Scleroderma Program offers a variety of treatment and care services for patients with scleroderma. These services include medical care, laboratory testing, imaging, and other diagnostic services. The program also provides access to medications and other treatments, such as physical therapy, occupational therapy, and speech therapy. Additionally, the program offers lifestyle advice and guidance on how to manage the condition and its symptoms.

Patient Education and Support

The program provides a range of patient education and support services. The team is committed to helping patients understand their condition and to provide them with the information they need to make informed decisions about their care. The program offers a variety of educational resources, such as pamphlets, videos, and webinars. Additionally, the program offers patient support groups, where patients can share their experiences and support one another.

Clinical Research and Studies

The Rutgers Health-RWJ Scleroderma Program is committed to advancing the field of scleroderma research and treatment. The program is actively involved in clinical research and studies aimed at improving the care and quality of life of scleroderma patients. The program has conducted a number of studies to better understand the disease, its causes, and its treatments. The program also participates in clinical trials to test new treatments and medications.